BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 34896059)

  • 1. Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography.
    Taplin SH; Abraham L; Geller BM; Yankaskas BC; Buist DS; Smith-Bindman R; Lehman C; Weaver D; Carney PA; Barlow WE
    J Natl Cancer Inst; 2010 Jul; 102(14):1040-51. PubMed ID: 20601590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health benefits and harms of mammography screening in older women (75+ years)-a systematic review.
    Mathieu E; Noguchi N; Li T; Barratt AL; Hersch JK; De Bock GH; Wylie EJ; Houssami N
    Br J Cancer; 2024 Feb; 130(2):275-296. PubMed ID: 38030747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
    Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
    JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast biopsy patterns and findings among older women undergoing screening mammography: The role of age and comorbidity.
    Advani S; Abraham L; Buist DSM; Kerlikowske K; Miglioretti DL; Sprague BL; Henderson LM; Onega T; Schousboe JT; Demb J; Zhang D; Walter LC; Lee CI; Braithwaite D; O'Meara ES;
    J Geriatr Oncol; 2022 Mar; 13(2):161-169. PubMed ID: 34896059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.
    Buist DSM; Abraham L; Lee CI; Lee JM; Lehman C; O'Meara ES; Stout NK; Henderson LM; Hill D; Wernli KJ; Haas JS; Tosteson ANA; Kerlikowske K; Onega T;
    JAMA Intern Med; 2018 Apr; 178(4):458-468. PubMed ID: 29435556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium.
    Allison KH; Abraham LA; Weaver DL; Tosteson AN; Nelson HD; Onega T; Geller BM; Kerlikowske K; Carney PA; Ichikawa LE; Buist DS; Elmore JG
    Cancer; 2015 May; 121(9):1369-78. PubMed ID: 25603785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of screening mammography in the United States and the United kingdom.
    Smith-Bindman R; Chu PW; Miglioretti DL; Sickles EA; Blanks R; Ballard-Barbash R; Bobo JK; Lee NC; Wallis MG; Patnick J; Kerlikowske K
    JAMA; 2003 Oct; 290(16):2129-37. PubMed ID: 14570948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?
    Braithwaite D; Zhu W; Hubbard RA; O'Meara ES; Miglioretti DL; Geller B; Dittus K; Moore D; Wernli KJ; Mandelblatt J; Kerlikowske K;
    J Natl Cancer Inst; 2013 Mar; 105(5):334-41. PubMed ID: 23385442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography.
    Weaver DL; Rosenberg RD; Barlow WE; Ichikawa L; Carney PA; Kerlikowske K; Buist DS; Geller BM; Key CR; Maygarden SJ; Ballard-Barbash R
    Cancer; 2006 Feb; 106(4):732-42. PubMed ID: 16411214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in pre-operative needle biopsy use in invasive breast cancer diagnosis: a Dutch nationwide population study.
    Bulte JP; Simsek D; Bult P; de Wilt JHW; Strobbe LJA
    Acta Oncol; 2020 Dec; 59(12):1469-1473. PubMed ID: 33030998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening Mammography Outcomes: Risk of Breast Cancer and Mortality by Comorbidity Score and Age.
    Demb J; Abraham L; Miglioretti DL; Sprague BL; O'Meara ES; Advani S; Henderson LM; Onega T; Buist DSM; Schousboe JT; Walter LC; Kerlikowske K; Braithwaite D;
    J Natl Cancer Inst; 2020 Jun; 112(6):599-606. PubMed ID: 31593591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer statistics, 2019.
    DeSantis CE; Ma J; Gaudet MM; Newman LA; Miller KD; Goding Sauer A; Jemal A; Siegel RL
    CA Cancer J Clin; 2019 Nov; 69(6):438-451. PubMed ID: 31577379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal breast cancer screening strategies for older women: current perspectives.
    Braithwaite D; Demb J; Henderson LM
    Clin Interv Aging; 2016; 11():111-25. PubMed ID: 26893548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data.
    Nelson HD; O'Meara ES; Kerlikowske K; Balch S; Miglioretti D
    Ann Intern Med; 2016 Feb; 164(4):226-35. PubMed ID: 26756902
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.